Company Overview of Percivia LLC
Percivia LLC manufactures human cells used in the industrial manufacture of biopharmaceuticals. The company offers biosimilar molecules, such as monoclonal antibodies and therapeutic glycoproteins. Percivia LLC was formerly known as Percivia PER.C6 Development Center and changed its name to Percivia LLC in September 2010. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. Percivia LLC operates as a joint venture between Crucell N.V. and Royal DSM N.V.
One Hampshire Street
Cambridge, MA 02139
Founded in 2006
Key Executives for Percivia LLC
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Percivia LLC, please visit www.percivia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.